Bernard Wealth Management’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Other funds holding PFE
VCM
VPM
Bernard Wealth Management's PFE Position: Q1 2026 in Review
Bernard Wealth Management increased its Pfizer (PFE) stake by 0.22% in Q1 2026, buying an estimated $53 and bringing the position to 921 shares worth $25.9K. The position accounts for 0.01% of the portfolio, ranked #167.
Bernard Wealth Management first reported a position in PFE in Q4 2024 and has held it in 6 quarters since. The position peaked at $30.1K in Q4 2024. 2,934 funds tracked by Wall St. Rank hold PFE as of Q1 2026.
- Bernard Wealth Management held 921 shares of Pfizer worth $25.9K as of Q1 2026.
- Bernard Wealth Management bought 2 Pfizer shares in Q1 2026, an estimated $53.
- Pfizer made up 0.01% of Bernard Wealth Management's portfolio in Q1 2026, its #167 holding.
- Bernard Wealth Management first reported a position in Pfizer in Q4 2024 and has held it in 6 quarters since.
- Bernard Wealth Management's Pfizer position peaked at $30.1K in Q4 2024.
- 2,934 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.
Based on Bernard Wealth Management's 13F filing for Q1 2026, filed 15 May 2026.